Study says unit-dose blister packaging’s demand to grow in future

Many diseases will be cured with a single-dose injectable vaccine soon

Study says unit-dose blister packaging’s demand to grow in future
The Freedonia Group study says single-dose packaging systems’ demand to grow in future. Photo credit: Jakayla Toney on Unsplash

Patient adherence, injection prevention, heightened drug production, and self-administration are some of the primary drivers of the estimated 6.4% annual growth of the containers of a unit-dose, and it is expected to hit US$57.9 billion by the end of 2025, according to the new analysis of Freedonia Group.

The blister packaging for solid dose applications will lead the worldwide market. The parenteral vials and pre-fillable syringes will encounter the fastest growth. Enhancing patient compliance through packaging designs is one of the significant trends that support the unit-dose market. This will accelerate the blister and strip pack usage. Clinical drug trials will boost the growth prospects for the unit-dose packaging systems promoting recordkeeping and compliance.

The Freedonia Group analysis predicts that due to the increased need for better infection control systems, the use of pen adaptable cartridges, auto-retractable pre-fillable syringes, and high-barrier parenteral vials would increase throughout the world’s medical community. It is a response to the requirement for improved infection prevention systems. 

Blister growth is driven by competition

The intensifying private and generic label competition promotes drug manufacturers to upgrade the containers to influence the medical providers’ and consumers’ purchasing decisions.

According to Freedonia analyst Bill Martineau, the imposed downward pricing pressures by private and public health insurance providers boost the personal and general label competition. Also, because of acquisitions and mergers, the number of proprietary drug distributors and makers is slightly decreasing, and the number of generic distributors and producers is increasing.

Efforts in enhancing the convenience and aesthetic properties of the pharma packaging apply massively to the over-the-counter supplements and drugs sold in retail stores. Also, enhancements in the ethical packaging of the drug include ease of delivery and infection prevention features.

Vaccines and new therapies demand unit-dose syringes

According to the study, biosimilar and new treatments for viral disorders, cancer, and several other debilitating problems will boost the demand for unit-dose parenteral vials and pre-fillable syringes. Martineau says that all these drugs are packaged in unit-dose containers almost always.

Additionally, the current enhancements in syringe safety and design are responsible for the rise in the therapies approved for self-injection. Therefore, it accelerates the demand for unit-dose parenteral vials and pre-fillable syringes. According to Martineau, self-injection therapies are mostly packages in either multi-use devices with cartridges or single-dose syringes.

An increased focus on infection prevention in the delivery system of the parenteral drug in clinics, hospitals, nursing homes, and physicians’ offices also contributes to the rise of unit-dose parenteral vials and syringes.

To conclude, the demand for all these unit-dose formats will rise. It will be the response to the expansion of the worldwide preventive medicine that needs a single-dose injectable vaccine for the diseases like shingles, meningitis, influenza, and Covid-19. The medical sector is making drastic improvements. So, within the coming few years, it will elevate things to a whole new level. With technological advancement and heightened consumer demand, things will get intense very soon.

The impact, resilience, and growth of responsible packaging in a wide region are daily chronicled by Packaging South Asia.

A multi-channel B2B publication and digital platform such as Packaging South Asia is always aware of the prospect of new beginnings and renewal. Its 16-year-old print monthly, based in New Delhi, India has demonstrated its commitment to progress and growth. The Indian and Asian packaging industries have shown resilience in the face of ongoing challenges over the past three years.

As we present our publishing plan for 2023, India’s real GDP growth for the financial year ending 31 March 2023 will reach 6.3%. Packaging industry growth has exceeded GDP growth even when allowing for inflation in the past three years.

The capacity for flexible film manufacturing in India increased by 33% over the past three years. With orders in place, we expect another 33% capacity addition from 2023 to 2025. Capacities in monocartons, corrugation, aseptic liquid packaging, and labels have grown similarly. The numbers are positive for most of the economies in the region – our platform increasingly reaches and influences these.

Even given the disruptions of supply chains, raw material prices, and the challenge of responsible and sustainable packaging, packaging in all its creative forms and purposes has significant headroom to grow in India and Asia. Our context and coverage engulf the entire packaging supply chain – from concept to shelf and further – to waste collection and recycling. We target brand owners, product managers, raw material suppliers, packaging designers and converters, and recyclers.

In an admittedly fragmented and textured terrain, this is the right time to plan your participation and marketing support communication – in our impactful and highly targeted business platform. Tell us what you need. Speak and write to our editorial and advertising teams! For advertisement , for editorial and for subscriptions

– Naresh Khanna

Subscribe Now
unnamed 1


Subscribe to our Newsletter


Please enter your comment!
Please enter your name here